caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1982791562

Rafayel GevorkianM.D.

General PracticeLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Rafayel Gevorkian's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 21 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Biocorp Clinical Lab Inc
Clinical Laboratory · Whittier, CA
3725,926
CHJ DIAGNOSTIC, INC.191547
ATLAS, THOMAS1911,328
Unilab Corporation
Clinical Laboratory · West Hills, CA
50158
Adelaida Bustos
Diagnostic Radiology · Los Angeles, CA
49470
DIGNITY COMMUNITY CARE40153
LEVINE, STEPHEN31244
Garo Pehlevanian
Cardiology · Los Angeles, CA
28142
City Of Los Angeles
Ambulance Service Provider · Los Angeles, CA
2583
Don Lee
Interventional Cardiology · Glendale, CA
22310
DIRECT NURSING SERVICES, INC22126
Ara Kadoyan
Psychiatry · Glendale, CA
17223
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,260
Unique beneficiaries
—
Total services
10,014
Distinct HCPCS
11
Medicare payment
$567K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 551 General Practice providers in CA — top quintile (cohort median 588).
PRESCRIBING · PART D · 2024
Total Rx claims
33,535
Beneficiaries
—
Total drug cost
$2.9M
Distinct drugs
215
Brand share
30.0%
Top prescribed drugs
Icosapent Ethyl1,082 claims
Rosuvastatin Calcium1,054 claims
Donepezil Hcl987 claims
Baclofen943 claims
Furosemide888 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
47.7
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$79
Payment records
4
By payment type
Food and Beverage$79